Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2004-11-12
2008-08-19
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S093100, C424S093400, C424S184100, C424S234100, C424S278100, C424S282100, C435S243000, C435S252100, C435S253200
Reexamination Certificate
active
07413728
ABSTRACT:
Use of an immune modulator composition and/or pharmaceutical composition comprising a whole cell of a bacterium from the generaRhodococcus, Gordonia, Nocardia, Dietzia, TsukamurellaandNocardioides, for use in the manufacture of a medicament for the treatment of an autoimmune disease or autoimmune disorder, including certain vascular disorders.
REFERENCES:
patent: 4599310 (1986-07-01), Matson et al.
patent: 706122 (1999-06-01), None
patent: WO 85/05034 (1985-11-01), None
patent: WO 03/049752 (2003-06-01), None
patent: WO 2004/022093 (2004-03-01), None
Kunkel, H.G., “Part V, Immune Disease”, in, Cecil Textbook of Medicine, eds. Beeson, McDermott, & Whyngaarden, 15thedition, W.B. Saunders Company, Phila., PA, 1979pp. 126-163.
Conforti, Anita, et al., “Specific and long lasting suppression of rat adjuvant arthritis by low-doseMycobacterium butyricum,” European Journal of Pharmacology, vol. 324 No. 2-3 (1997) pp. 241-247.
Zuany-Amorim et al., “Long-Term Protective and Antigen-Specific Effect of Heat-KilledMycobacterium vaccaein a Murine Model of Allergic Pulmonary Inflammation,”The Journal of Immunology, 169: 1492-1499 (2002).
Stansby et al., “Prevention of Experimental Myointimal Hyperplasia by Immunomodulation,”Eur. J. Vasc. Endovasc. Surg., 23:23-28 (2002).
Haanen et al., “Selection of a Human T Helper Type 1-like T cell Subset by Mycobateria,”J. Exp. Med., 174: 583-592 (1991).
Stanford et al., “Immunotherapy with Mycobacterium Vaccae in the Treatment of Tuberculosis,”Frontiers in Bioscience, 9: 1701-1719 (2004).
Smit et al., “Therapeutic treatment with heat-killedMycobacterium vaccae(SRL172) in a mild and severe mouse model for allergic asthma,”European Journal of Pharmacology, 470: 193-199 (2003).
Bottasso Oscar Adelmo
McIntyre Graham
Stanford Cynthia Ann
Stanford John Lawson
Steptoe & Johnson LLP
Swartz Rodney P.
UCL Biomedica PLC
LandOfFree
Immune modulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune modulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune modulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993247